International Journal of Medical Science and Pharmaceutical Research

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a relevant target for the identification of novel antiviral compounds. In this study, we investigated the molecular interactions between a plant-derived lectin from Dioclea altissima (DAL) and two key viral targets: the main protease (Mpro) and the spike glycoprotein. Molecular docking simulations were performed using HEX 8.0.0 to explore protein–protein interactions between the lectin and SARS-CoV-2 targets. The results revealed a markedly higher docking score of DAL toward Mpro (−83.73) compared to the spike protein (−40.71). Structural analysis of the top-ranked docking poses indicated that DAL interacts with amino acid residues in regions proximal to the catalytic site of Mpro, suggesting a potential influence on substrate accessibility or local conformational dynamics. In contrast, interactions with the spike protein were observed within the S2 subunit, outside the canonical receptor-binding domain, involving regions associated with conformational rearrangements required for membrane fusion. Visualization and interaction analyses were conducted using PyMOL, enabling the identification of key contact residues and interaction patterns contributing to complex stabilization. The comparative binding profile suggests preferential interaction of DAL with Mpro, supporting its potential as a scaffold for the development of antiviral agents against SARS-CoV-2. These findings provide preliminary in silico evidence of selective interaction between D. altissima lectin and a key viral enzyme, warranting further biochemical and pharmacological investigations.

SARS-CoV-2, Molecular docking, Dioclea altissima Lectin, Antiviral compounds.

1. Andrade CH, et al. Modelagem molecular no ensino de química farmacêutica. Rev Eletr Farm. 2010;7:1–23.
2. Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020;368(6497):1331–1335. Available from: https://www.science.org/doi/10.1126/science.abb4489
3. DeLano WL. The PyMOL Molecular Graphics System, version 1.8. Schrödinger LLC; 2014. Available from: http://www.pymol.org
4. Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289–293. Available from: https://doi.org/10.1038/s41586-020-2223-y
5. Macindoe G, Mavridis L, Venkatraman V, Devignes MD, Ritchie DW. HexServer: an FFT-based protein docking server powered by graphics processors. Nucleic Acids Res. 2010;38(Web Server issue):W445–W449. Avaiable from: https://doi.org/10.1093/nar/gkq311
6. Qamar MT, Alqahtani SM, Alamri MA, Chen LL. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10(4):313–319. Available from: https://doi.org/10.1016/j.jpha.2020.03.009
7. World Health Organization (WHO). COVID-19 Weekly Epidemiological Update 55. 2022. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/weekly_epidemiological_update_22.pdf
8. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. Available from: https://www.science.org/doi/10.1126/science.abb250
9. Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020;368(6489):409–412. Available from: https://www.science.org/doi/10.1126/science.abb3405
10. Zíngolo MA, et al. Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools. Sci Total Environ. 2021;781:146400. Available from: https://doi.org/10.1016/j.scitotenv.2021.146400